Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Silo Pharma Inc
SILO
Healthcare
Biotechnology
Silo Pharma, Inc. is a developmental stage biopharmaceutical company. The Company is focused on developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It is engaged in acquiring and/or developing intellectual property or technology rights from universities and...
researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin, and the potential benefits they may have in certain cases involving depression, mental health issues and neurological disorders. The Company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. Its SP-26 is a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. Its two preclinical programs are SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:SILO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(109)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jun 26, 2024 10:15pm
InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Collabo
NEWS: $SILO InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Collaborates with CRO Partner to Advance SPC-15 for PTSDSilo Pharma (NASDAQ: SILO) is a developmental stage biopharmaceutical company
...more
(109)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jun 05, 2024 5:45pm
Silo Pharma Announces $2 Million Registered Direct Offering
JUST IN: $SILO Silo Pharma Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesSARASOTA, FL, June 05, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (&
...more
(109)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jun 04, 2024 4:15pm
InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) An
Just In: $SILO InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Announces Pre-IND Submission for Proprietary Treatment for PTSD, AnxietySilo Pharma (NASDAQ: SILO) , a developmental-stage
...more
(109)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jun 04, 2024 1:30pm
Silo Pharma Submits Pre-Investigational New Drug Application
BREAKING NEWS: $SILO Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and AnxietyClinical roadmap unveiled for novel and proprietary intranasal
...more
(109)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 14, 2024 8:00pm
Silo Pharma's SP-26 Ketamine Implant Demonstrates Successful
News; $SILO Silo Pharma's SP-26 Ketamine Implant Demonstrates Successful Drug DeliveryInitial indications target fibromyalgia and chronic pain Loaded and encapsulated drug maintains structural
...more
(60)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 14, 2024 8:55am
SILO....On watch list @ $1.65
Early a.m NR Silo Pharma ¢ € ™s SP-26 Ketamine Implant Demonstrates Successful Drug Delivery 2024-02-14 05:45 ET - News Release Initial indications target
...more
(60)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 21, 2023 3:50pm
SILO.....LoL.....scalped ; )
Thanks Mr. M ; )
(60)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 21, 2023 3:44pm
SILO....nobody is that gullible to fall for your smack
lol
(60)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 21, 2023 3:41pm
SILO....now thats a spread !!!
Looser
(60)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 21, 2023 3:39pm
SILO...Thats what u get for lovin me....
a big bag that hangs below his knees ; )
(60)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 21, 2023 3:29pm
SILO.... Volume at a stand still post P & D
LoL....shell shocked Chasers don't want to sell I'd say ...Lights are on but nobody's home Sayannara
(60)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 21, 2023 1:39pm
SILO...hurry up & dye !!!!
U have zero strength
(60)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 21, 2023 11:56am
SILO.....Only Bagholders are left
and zero volume now ...LoL What a game !
(60)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 21, 2023 11:21am
SILO.....4.2 million shs traded on the a.m NR ...and its red
Told ya this Maggot is a Maddapakka
(60)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 21, 2023 10:29am
SILO....this dude reminds me of a few deals
from the past......I wouldn't touch this with a 10 ft pole JMHO
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >